title: Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
authors.affiliation: Department of Orthopaedic Surgery, Spine and Scoliosis Service, Hospital for Special Surgery, Weill Cornell Medical College, 535 East 70th St, New York, NY 10021, USA.
authors.forename: Alexander
authors.initials: A
authors.lastname: Aichmair
authors.forename: Federico P
authors.initials: FP
authors.lastname: Girardi
authors.forename: Alexander P
authors.initials: AP
authors.lastname: Hughes
authors.forename: Andrew A
authors.initials: AA
authors.lastname: Sama
authors.forename: Darren R
authors.initials: DR
authors.lastname: Lebl
authors.forename: Frank P
authors.initials: FP
authors.lastname: Cammisa
mesh_terms: D000368:Aged; D055396:Bone Morphogenetic Protein 2 / Q000009:adverse effects*; D006801:Humans; D055959:Intervertebral Disc Degeneration / Q000601:surgery; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging / Q000601:surgery*; D008297:Male; D009999:Ossification, Heterotopic / Q000139:chemically induced* / Q000000981:diagnostic imaging; D016658:Psoas Muscles / Q000000981:diagnostic imaging / Q000473:pathology*; D011859:Radiography; D011994:Recombinant Proteins / Q000009:adverse effects; D013123:Spinal Fusion / Q000379:methods*; D013130:Spinal Stenosis / Q000601:surgery; D016212:Transforming Growth Factor beta / Q000009:adverse effects*
chemical_list: D055396:Bone Morphogenetic Protein 2; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2